Precision oxygen monitor study for infants
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial tests a new type of oxygen monitor (pulse oximeter) in babies under 1 year old. It helps doctors better track oxygen levels in critically ill infants to improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is less than 1 year old (up to 12 months).
- Your baby weighs more than 2 kilograms (about 4.4 pounds) at the time of the study.
- Your baby is in an intensive care unit (ICU).
- Your baby already has an arterial line (a small tube in an artery) as part of their regular care.
- You or the legal guardian can agree to the study and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how well a new Owlet sensor measures oxygen levels in newborns. It is for babies who already have an arterial line in place for routine blood tests.
This study tests a new way to measure oxygen levels in the blood of infants and children using a sensor on the skin. It may help doctors monitor oxygen without needing as many blood draws.
This study tests how well a new oxygen sensor (pulse oximeter) works on children in the cardiac intensive care unit. If your child already has an artery line placed for normal care, this sensor might give more accurate readings without any extra pokes.
This trial tests a new way to measure breathing using a standard oxygen sensor (pulse oximetry) and a special clip on the nose for children and adults. It's meant for people already having their blood oxygen checked regularly, and the goal is to see if the sensor can accurately track your breaths.
This study tests a way to monitor and adjust oxygen therapy from home for premature babies with a long-term lung condition called bronchopulmonary dysplasia. The goal is to see if remote monitoring can improve oxygen management and reduce complications.
This trial tests whether using a remote oxygen monitor at home can help prevent ER visits and re-hospitalization for infants leaving the NICU. It aims to see if this simple device can provide extra safety and peace of mind for families.
Hear when a new Single Ventricle Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.